# Computational analysis of hub genes associated with sarcopenia: integrative transcriptome insights from an Asian cohort

**Authors:** Jae Gyu Kim, Ashish Ranjan Sharma, Yeon-Hee Lee, Min-Jee Kwon, Chiranjib Chakraborty, Jin-Chul Kim, Holger Jahr, Sang-Soo Lee

PMC · DOI: 10.17179/excli2025-9087 · EXCLI Journal · 2026-01-02

## TL;DR

This study identifies four key genes linked to sarcopenia in an Asian population, offering insights into muscle-bone degeneration and potential treatment targets.

## Contribution

The study integrates transcriptomic and clinical data to identify novel hub genes associated with sarcopenia in Asian populations.

## Key findings

- Four hub genes (ADAM8, BECN1, KLF4, GBP5) were identified as critical in sarcopenia-related pathways.
- These genes showed strong inverse correlations with muscle mass and strength indicators.
- Sarcopenic individuals had significantly lower BMI, gait speed, and muscle mass compared to controls.

## Abstract

Sarcopenia, a progressive loss of skeletal muscle mass and strength, leads to frailty, falls, fractures, and delayed recovery following orthopedic surgery. When combined with osteoporosis, it manifests as osteosarcopenia, exacerbating musculoskeletal fragility. Although chronic inflammation, mitochondrial dysfunction, and impaired autophagy are recognized contributors, the integrated regulation of these processes in Asian populations remains unclear. This study aimed to elucidate molecular mediators and signaling pathways connecting inflammation, autophagy, and muscle-bone degeneration using an integrated clinical-transcriptomic approach. Transcriptomic data (GSE226151) comprising vastus lateralis muscle samples from 20 sarcopenic patients and 20 age- and sex-matched healthy Asian controls were analyzed using ExDEGA, with differentially expressed genes (DEGs) defined by |log₂ fold change| ≥ 1 and FDR < 0.05. Functional enrichment via ShinyGO identified key Gene Ontology and KEGG pathways, while STRING-Cytoscape network analysis revealed four hub genes-ADAM8, BECN1, KLF4, and GBP5-with high connectivity (degree >10) enriched in cytokine-cytokine receptor interaction and PI3K-Akt pathways. Gene Set Enrichment Analysis further validated these associations. The expression of these hub genes inversely correlated with skeletal muscle index (r = -0.63 to -0.74; p < 0.01) and grip strength (r = -0.58 to -0.69; p < 0.05). Clinically, sarcopenic individuals exhibited significantly lower BMI, gait speed, and muscle mass (all p < 0.001). Integrating bioinformatics and clinical data identified these four genes as critical mediators linking inflammation, defective autophagy, and musculoskeletal decline in sarcopenia. These findings provide translational insight into the molecular mechanisms underlying osteosarcopenia and suggest potential biomarkers and therapeutic targets to improve diagnosis and treatment in aging-related musculoskeletal disorders.

See also the graphical abstract(Fig. 1).

## Linked entities

- **Genes:** ADAM8 (ADAM metallopeptidase domain 8) [NCBI Gene 101], BECN1 (beclin 1) [NCBI Gene 8678], KLF4 (KLF transcription factor 4) [NCBI Gene 9314], GBP5 (guanylate binding protein 5) [NCBI Gene 115362]
- **Diseases:** osteoporosis (MONDO:0005298)

## Full-text entities

- **Genes:** NR4A3 (nuclear receptor subfamily 4 group A member 3) [NCBI Gene 8013] {aka CHN, CSMF, MINOR, NOR1}, ADAM8 (ADAM metallopeptidase domain 8) [NCBI Gene 101] {aka CD156, CD156a, MS2}, ACTN3 (actinin alpha 3) [NCBI Gene 89] {aka ACTN3D}, NFAM1 (NFAT activating protein with ITAM motif 1) [NCBI Gene 150372] {aka CNAIP}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, VNN2 (vanin 2) [NCBI Gene 8875] {aka FOAP-4, GPI-80}, PIM1 (Pim-1 proto-oncogene, serine/threonine kinase) [NCBI Gene 5292] {aka PIM}, TICAM1 (TIR domain containing adaptor molecule 1) [NCBI Gene 148022] {aka IIAE6, MyD88-3, PRVTIRB, TICAM-1, TRIF}, TPPP3 (tubulin polymerization promoting protein family member 3) [NCBI Gene 51673] {aka CGI-38, TPPP/p20, p20, p25gamma}, INSRR (insulin receptor related receptor) [NCBI Gene 3645] {aka IRR}, MYBPC2 (myosin binding protein C2) [NCBI Gene 4606] {aka MYBPC, MYBPCF, fsMyBP-C}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CXCR1 (C-X-C motif chemokine receptor 1) [NCBI Gene 3577] {aka C-C, C-C-CKR-1, CD128, CD181, CDw128a, CKR-1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, RASD1 (ras related dexamethasone induced 1) [NCBI Gene 51655] {aka AGS1, DEXRAS1, MGC:26290}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, XIRP1 (xin actin binding repeat containing 1) [NCBI Gene 165904] {aka CMYA1, Xin}, MYH6 (myosin heavy chain 6) [NCBI Gene 4624] {aka ASD3, CMD1EE, CMH14, MYHC, MYHCA, SSS3}, NMRK2 (nicotinamide riboside kinase 2) [NCBI Gene 27231] {aka ITGB1BP3, MIBP, NRK2}, TRIM63 (tripartite motif containing 63) [NCBI Gene 84676] {aka CMH31, IRF, MURF1, MURF2, RNF28, SMRZ}, SNAP25 (synaptosome associated protein 25) [NCBI Gene 6616] {aka CMS18, DEE117, RIC-4, RIC4, SEC9, SNAP}, CLEC7A (C-type lectin domain containing 7A) [NCBI Gene 64581] {aka BGR, CANDF4, CD369, CLECSF12, DECTIN1, SCARE2}, CXCR2 (C-X-C motif chemokine receptor 2) [NCBI Gene 3579] {aka CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB}, KLF4 (KLF transcription factor 4) [NCBI Gene 9314] {aka EZF, GKLF}, ARID5B (AT-rich interaction domain 5B) [NCBI Gene 84159] {aka DESRT, MRF-2, MRF2}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, ANKRD2 (ankyrin repeat domain 2) [NCBI Gene 26287] {aka ARPP}, GBP5 (guanylate binding protein 5) [NCBI Gene 115362] {aka GBP-5}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CSF2RB (colony stimulating factor 2 receptor subunit beta) [NCBI Gene 1439] {aka CD131, CDw131, IL3RB, IL5RB, SMDP5, betaGMR}, MYH8 (myosin heavy chain 8) [NCBI Gene 4626] {aka DA7, MyHC-peri, MyHC-pn, gtMHC-F}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, CFLAR (CASP8 and FADD like apoptosis regulator) [NCBI Gene 8837] {aka CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1}, FPR1 (formyl peptide receptor 1) [NCBI Gene 2357] {aka FMLP, FPR}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, APOLD1 (apolipoprotein L domain containing 1) [NCBI Gene 81575] {aka BDVAS, VERGE}, SKI (SKI proto-oncogene) [NCBI Gene 6497] {aka SGS, SKV}, HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2) [NCBI Gene 3158], HK2 (hexokinase 2) [NCBI Gene 3099] {aka HKII, HXK2}, CSRNP1 (cysteine and serine rich nuclear protein 1) [NCBI Gene 64651] {aka AXUD1, CSRNP-1, FAM130B, TAIP-3, URAX1}, TRIB1 (tribbles pseudokinase 1) [NCBI Gene 10221] {aka C8FW, GIG-2, GIG2, SKIP1, TRB-1, TRB1}, TNNC1 (troponin C1, slow skeletal and cardiac type) [NCBI Gene 7134] {aka CMD1Z, CMH13, TN-C, TNC, TNNC}, HECTD2 (HECT domain E3 ubiquitin protein ligase 2) [NCBI Gene 143279], CSF3R (colony stimulating factor 3 receptor) [NCBI Gene 1441] {aka CD114, GCSFR, SCN7}, SIRPA (signal regulatory protein alpha) [NCBI Gene 140885] {aka BIT, CD172A, MFR, MYD-1, MYD1, P84}, JAML (junction adhesion molecule like) [NCBI Gene 120425] {aka AMICA, AMICA1, CREA7-1, CREA7-4, Gm638}, FCGR3B (Fc gamma receptor IIIb) [NCBI Gene 2215] {aka CD16, CD16-I, CD16b, FCG3, FCGR3, FCRIIIb}, NANOS1 (nanos C2HC-type zinc finger 1) [NCBI Gene 340719] {aka EC_Rep1a, NOS-1, NOS1, SPGF12, ZC2HC12A}, SMAD7 (SMAD family member 7) [NCBI Gene 4092] {aka CRCS3, MADH7, MADH8}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}, MEFV (MEFV innate immunity regulator, pyrin) [NCBI Gene 4210] {aka FMF, MEF, PAAND, TRIM20}, AKR1C1 (aldo-keto reductase family 1 member C1) [NCBI Gene 1645] {aka 2-ALPHA-HSD, 20-ALPHA-HSD, DD1, DD1/DD2, DDH, DDH1}, SELL (selectin L) [NCBI Gene 6402] {aka CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL}, GFM1 (G elongation factor mitochondrial 1) [NCBI Gene 85476] {aka COXPD1, EFG, EFG1, EFGM, EGF1, GFM}, DMPK (DM1 protein kinase) [NCBI Gene 1760] {aka DM, DM1, DM1PK, DMK, MDPK, MT-PK}, IGFN1 (immunoglobulin like and fibronectin type III domain containing 1) [NCBI Gene 91156] {aka EEF1A2BP1}, SAMD7 (sterile alpha motif domain containing 7) [NCBI Gene 344658] {aka MDCD}
- **Diseases:** loss of muscle mass (MESH:C536030), frailty (MESH:D000073496), skeletal muscle disorder (MESH:D005207), metabolic (MESH:D008659), osteopenia (MESH:D001851), falls (MESH:C537863), asthma (MESH:D001249), Alzheimer's disease (MESH:D000544), mitochondrial failure (MESH:D051437), fractures (MESH:D050723), muscle contraction (MESH:C536214), muscle (MESH:D019042), Mitochondrial dysfunction (MESH:D028361), pancreatic cancer (MESH:D010190), neurodegenerative disorders (MESH:D019636), Inflammatory (MESH:D007249), muscle atrophy (MESH:D009133), Sarcopenia (MESH:D055948), chronic diseases (MESH:D002908), infectious diseases (MESH:D003141), muscular dystrophy (MESH:D009136), neuromuscular dysfunction (MESH:D009468), muscle deterioration (MESH:D009135), muscle degeneration (MESH:D009410), musculoskeletal condition (MESH:D009140), muscle-bone degeneration (MESH:D001847), osteoporosis (MESH:D010024), age (MESH:D019588), malnutrition (MESH:D044342), hip fractures (MESH:D006620)
- **Chemicals:** glucose (MESH:D005947), ROS (MESH:D017382), lipid (MESH:D008055), ATP (MESH:D000255)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946438/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12946438/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946438/full.md

---
Source: https://tomesphere.com/paper/PMC12946438